BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8566583)

  • 1. High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression.
    Tsushima H; Kawata S; Tamura S; Ito N; Shirai Y; Kiso S; Imai Y; Shimomukai H; Nomura Y; Matsuda Y; Matsuzawa Y
    Gastroenterology; 1996 Feb; 110(2):375-82. PubMed ID: 8566583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of transforming growth factor beta1 as a new tumor marker for colorectal cancer.
    Narai S; Watanabe M; Hasegawa H; Nishibori H; Endo T; Kubota T; Kitajima M
    Int J Cancer; 2002 Feb; 97(4):508-11. PubMed ID: 11802214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection.
    Shim KS; Kim KH; Han WS; Park EB
    Cancer; 1999 Feb; 85(3):554-61. PubMed ID: 10091729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer.
    Tsushima H; Ito N; Tamura S; Matsuda Y; Inada M; Yabuuchi I; Imai Y; Nagashima R; Misawa H; Takeda H; Matsuzawa Y; Kawata S
    Clin Cancer Res; 2001 May; 7(5):1258-62. PubMed ID: 11350892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients.
    Robson H; Anderson E; James RD; Schofield PF
    Br J Cancer; 1996 Sep; 74(5):753-8. PubMed ID: 8795578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
    Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M
    Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of TGF-beta receptors in human colorectal cancer: implications for cancer development.
    Matsushita M; Matsuzaki K; Date M; Watanabe T; Shibano K; Nakagawa T; Yanagitani S; Amoh Y; Takemoto H; Ogata N; Yamamoto C; Kubota Y; Seki T; Inokuchi H; Nishizawa M; Takada H; Sawamura T; Okamura A; Inoue K
    Br J Cancer; 1999 Apr; 80(1-2):194-205. PubMed ID: 10389996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta1 in invasion and metastasis in colorectal cancer.
    Xiong B; Yuan HY; Hu MB; Zhang F; Wei ZZ; Gong LL; Yang GL
    World J Gastroenterol; 2002 Aug; 8(4):674-8. PubMed ID: 12174377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer.
    Friedman E; Gold LI; Klimstra D; Zeng ZS; Winawer S; Cohen A
    Cancer Epidemiol Biomarkers Prev; 1995; 4(5):549-54. PubMed ID: 7549813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum levels of transforming growth factor-alpha in patients with colorectal cancer.
    Shim KS; Kim KH; Park BW; Yi SY; Choi JH; Han WS; Park EB
    Dis Colon Rectum; 1998 Feb; 41(2):219-24. PubMed ID: 9556248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor.
    Kong FM; Anscher MS; Murase T; Abbott BD; Iglehart JD; Jirtle RL
    Ann Surg; 1995 Aug; 222(2):155-62. PubMed ID: 7543740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulated expression of transforming growth factor beta 1 mRNA in endometrial carcinoma.
    Perlino E; Loverro G; Maiorano E; Giannini T; Cazzolla A; Napoli A; Fiore MG; Ricco R; Marra E; Selvaggi L
    Br J Cancer; 1998 Apr; 77(8):1260-6. PubMed ID: 9579831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy.
    Shariat SF; Shalev M; Menesses-Diaz A; Kim IY; Kattan MW; Wheeler TM; Slawin KM
    J Clin Oncol; 2001 Jun; 19(11):2856-64. PubMed ID: 11387358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta 1 in colonic neoplasia. A genetic molecular and immunohistochemical study.
    Cardillo MR; Yap EP
    Arch Anat Cytol Pathol; 1996; 44(5-6):241-9. PubMed ID: 9339011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression.
    Biasi F; Tessitore L; Zanetti D; Cutrin JC; Zingaro B; Chiarpotto E; Zarkovic N; Serviddio G; Poli G
    Gut; 2002 Mar; 50(3):361-7. PubMed ID: 11839715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-β1 gene promoter -509C/T polymorphism in association with expression affects colorectal cancer development and depends on gender.
    Stanilova S; Stanilov N; Julianov A; Manolova I; Miteva L
    PLoS One; 2018; 13(8):e0201775. PubMed ID: 30071009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma.
    Ito N; Kawata S; Tamura S; Takaishi K; Shirai Y; Kiso S; Yabuuchi I; Matsuda Y; Nishioka M; Tarui S
    Cancer Res; 1991 Aug; 51(15):4080-3. PubMed ID: 1649698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated plasma levels of transforming growth factor-beta 1 (TGF-beta 1) in patients with advanced breast cancer: association with disease progression.
    Ivanović V; Todorović-Raković N; Demajo M; Nesković-Konstantinović Z; Subota V; Ivanisević-Milovanović O; Nikolić-Vukosavljević D
    Eur J Cancer; 2003 Mar; 39(4):454-61. PubMed ID: 12751375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
    Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
    PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.